Log in

NASDAQ:AIKIAIkido Pharma Stock Price, Forecast & News

-0.02 (-2.39 %)
(As of 07/3/2020 04:00 PM ET)
Today's Range
Now: $0.82
50-Day Range N/A
52-Week Range
Now: $0.82
Volume1.97 million shs
Average Volume5.09 million shs
Market Capitalization$28.48 million
P/E RatioN/A
Dividend YieldN/A
AIkido Pharma Inc., a biotechnology development company, focuses on developing small-molecule anti-cancer therapeutics. The company engages in the development of therapeutic drugs for the treatment of pancreatic cancer, acute myeloid leukemia (AML), and acute lymphoblastic leukemia (ALL). Its portfolio includes KPC-34 for the treatment of AML and ALL; and DHA-dFdC drug for the treatment of pancreatic cancer. AIkido Pharma Inc. has an artificial intelligence and machine learning research agreement with Cogia Biotech LTD. The company was formerly known as Spherix Incorporated and changed its name to AIkido Pharma Inc. in March 2020. AIkido Pharma Inc. was founded in 1967 and is based in New York, New York.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 0.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.13 out of 5 stars

Industry, Sector and Symbol

Industry Commercial physical research
Current SymbolNASDAQ:AIKI



Sales & Book Value

Annual Sales$10,000.00
Book Value$2.18 per share


Net Income$-4,180,000.00


Market Cap$28.48 million
Next Earnings Date8/12/2020 (Estimated)
OptionableNot Optionable

Receive AIKI News and Ratings via Email

Sign-up to receive the latest news and ratings for AIKI and its competitors with MarketBeat's FREE daily newsletter.

AIkido Pharma (NASDAQ:AIKI) Frequently Asked Questions

When is AIkido Pharma's next earnings date?

AIkido Pharma is scheduled to release its next quarterly earnings announcement on Wednesday, August 12th 2020. View our earnings forecast for AIkido Pharma.

How were AIkido Pharma's earnings last quarter?

AIkido Pharma Inc. (NASDAQ:AIKI) issued its quarterly earnings data on Thursday, May, 14th. The company reported ($0.91) earnings per share (EPS) for the quarter. View AIkido Pharma's earnings history.

Has AIkido Pharma been receiving favorable news coverage?

Media headlines about AIKI stock have been trending negative this week, InfoTrie reports. InfoTrie identifies positive and negative press coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. AIkido Pharma earned a coverage optimism score of -2.2 on InfoTrie's scale. They also gave media stories about the company a news buzz of 5.0 out of 10, indicating that recent press coverage is somewhat likely to have an impact on the stock's share price in the next few days. View the latest news about AIkido Pharma.

Who are some of AIkido Pharma's key competitors?

What is AIkido Pharma's stock symbol?

AIkido Pharma trades on the NASDAQ under the ticker symbol "AIKI."

How do I buy shares of AIkido Pharma?

Shares of AIKI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is AIkido Pharma's stock price today?

One share of AIKI stock can currently be purchased for approximately $0.82.

How big of a company is AIkido Pharma?

AIkido Pharma has a market capitalization of $28.48 million and generates $10,000.00 in revenue each year. AIkido Pharma employs 3 workers across the globe.

What is AIkido Pharma's official website?

The official website for AIkido Pharma is www.spherix.com.

How can I contact AIkido Pharma?

AIkido Pharma's mailing address is ONE ROCKEFELLER PLAZA 11TH FLOOR, NEW YORK NY, 10020. The company can be reached via phone at 703-992-9325 or via email at [email protected]

This page was last updated on 7/5/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.